GGrantIndex
← Search

Safety, tolerability &pharmacokinetics of SDZ RAD in de novo liver transplant

$0M01FY2000RRNIH

Tufts Medical Center, Boston MA

Investigators

Linked publications & trials

Abstract

A one-year multi-center randomized, placebo controlled double-blind, parallel, group, dose finding study to evaluate the safety, tolerability and pharmacokinetics of rad001 in de novo liver transplant recipients (cradoo1B158)"

View original record on NIH RePORTER →